Adrienne G. Randolph, MD, MSc

Boston Children's Hospital, Harvard Medical School

Disclosure(s): Thermo Fisher, Inc.: Advisor/Consultant; UpToDate Inc.: Section editor, Pediatric Critical Care

Poster(s):

• (P-708) Clinical characteristics and outcomes among critically ill children aged 8 to 24 months with RSV lower respiratory tract infection by nirsevimab eligibility status – October 2023 – April 2025
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET